Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,700 and growing rapidly – covering all major disease areas
Help shape the future of health research with Olink’s cutting-edge technology
Filters
Therapeutic Advances in Endocrinology and Metabolism, 2025Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses
Zhang Y., Wang B., Chen B. et al.
Olink Explore 3072/384
Arthritis & Rheumatology, 2025Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development
Rachid Zaim S., Savage A., Gillespie M. et al.
Olink Target 96
Health Science Reports, 2025Unveiling the Intricate Causal Nexus Between 91 Circulating Inflammatory Proteins and Perianal Abscess Through a Comprehensive Bidirectional Two‐Sample Mendelian Randomization Analysis
Wang Z., Chen T., Shi H. et al.
International Journal of Biological Macromolecules, 2025Causal relationship between 91 circulating inflammatory proteins and gynecological diseases: A two-sample bidirectional Mendelian randomization study
Wang J., Zhang P., Yuan J. et al.
Journal of Infection, 2025Multi-omics analysis of human plasma reveals reprogramming of tryptophan metabolism associated with inflammation in Mycoplasma pneumoniae pneumonia in children
Tang Y., Fu X., Li X. et al.
Polish Heart Journal, 2025ST2, CLSTN2, IGFBP-7 and GDNF proteins gene expressions are associated with presence of carotid plaques in the general population independently from classical risk factors: A cross-sectional study
Szpakowicz A., Tuchliński J., Szum-Jakubowska A. et al.
Journal of Inflammation Research, 2025Using Olink Proteomics to Identify Inflammatory Biomarkers in the Cerebrospinal Fluid in Guillain-Barré Syndrome
Sun S., Li M., Song J. et al.
International Journal of Cardiology Cardiovascular Risk and Prevention, 2025Circulating protein biomarkers and their association with vulnerable plaque characteristics – a PROSPECT II substudy
Sharma T., Maehara A., Maeng M. et al.
Vaccines, 2025A DNA Vaccine Against Proadrenomedullin N-Terminal 20 Peptide (PAMP) Reduces Angiogenesis and Increases Lymphocyte and Macrophage Infiltration but Has No Effect on Tumor Burden in a Mouse Model of Lung Metastasis
Raju T., Tadic S., Garrido P. et al.
Olink Target 48 Mouse
PLOS One, 2025Serum IL-6 and PTX3 predict severe outcome from COVID-19 in ambulatory subjects: Impact for future therapeutic decisions
Poorbaugh J., Sims J., Zhang L. et al.
Nature Communications, 2025Multi-organ metabolome biological age implicates cardiometabolic conditions and mortality risk
Zalesky A., Tian Y., Ferrucci L. et al.
European Journal of Endocrinology, 2025Proteomic variation underlies the heterogeneous risk of metabolic dysfunction-associated steatotic liver disease for subsequent chronic diseases
Wu J., Wu G., Li J. et al.
Nature Communications, 2025SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults’ responses
Nehar-Belaid D., Mejías A., Xu Z. et al.
Scientific Reports, 2025The contribution of oral infectious diseases in lacunar stroke based on meta-analysis and Mendelian randomization study
Zheng Q., Xu T., Luo S. et al.
Journal of the American Heart Association, 2025Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention
El‐Sabawi B., Tanriverdi K., Gajjar P. et al.
Journal of the American Heart Association, 2025Systemic Changes in Adults With a Fontan Circulation: Insights From the Plasma Proteome
Kelly B., Ravndal M., Bach P. et al.
Scientific Reports, 2025Dissecting immune-mediated pathways in rheumatoid arthritis: A multivariate mediation analysis of antibodies and circulating proteins
Niu J., Zhang P., Liu W. et al.
BMC Neurology, 2025CD28+ CD45RA− CD8br AC mediated the effects of Interleukin- 6 on Alzheimer's disease: A Mendelian Randomization Study
Xu R., Gao Y.
Journal for ImmunoTherapy of Cancer, 2025Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control
Maldonado M., Gracia-Hernandez M., Le L. et al.
Blood Journal, 2025Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment
Pelzl R., Benintende G., Gsottberger F. et al.
2775 publications
Items per page
21-40 of 2775 publications